New AAP Study: Starting HPV Vaccine at Ages 9–10 Does Not Increase Parental Hesitancy

Back-to-school checkups bring a recurring conversation for many families with school-age children: the HPV vaccine. And for parents who have wondered whether starting earlier makes the conversation harder, new research published in the American Academy of Pediatrics' flagship journal offers a reassuring finding.

A study in the August 2026 issue of Pediatrics found that offering HPV vaccination to children at ages 9–10 did not increase parental hesitancy compared with the standard recommended window of ages 11–12. Clinicians involved in the study reported similar levels of questions, concerns, and vaccine acceptance regardless of when they introduced the conversation.

Why HPV Vaccination Matters

The HPV (human papillomavirus) vaccine protects against virus strains that can lead to multiple types of cancer, including cervical, throat, and anal cancers. It is most effective when given before potential exposure to the virus, which is why vaccination is recommended during childhood and early adolescence.

The vaccine is given as a series. Children who start the series before age 15 typically need only two doses; those who start at 15 or older need three. Starting at ages 9–10 completes the series on a longer timeline with less scheduling pressure and provides a longer window of established immunity.

What This Means for COS Families

If your child is between the ages of 9 and 14 and has not yet started the HPV vaccine series, the back-to-school period is a natural time to have that conversation with your pediatrician. Many Colorado Springs pediatricians offer combined well-child visits that include vaccine catch-up appointments during August and September.

If you have questions about the HPV vaccine — including what it protects against, how many doses are needed, and what side effects to expect — your child's primary care provider is the best first resource. You can also find evidence-based information through the AAP (aap.org) and the CDC (cdc.gov).

What's Next

The findings from this study are consistent with a broader trend in pediatric medicine toward earlier engagement on vaccines that benefit from more lead time. For COS families, the most actionable step is to bring this research to your child's next well-child visit and ask your pediatrician whether an earlier HPV vaccination start makes sense for your family.